What does CUSIP 92243G108 represent in this 13F holders report?

CUSIP 92243G108 is the security identifier for PCVX - Vaxcyte, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held PCVX - Vaxcyte, Inc. - Common Stock in Q1 2021?

73 institutional investors reported PCVX - Vaxcyte, Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Vaxcyte, Inc. - Common Stock (PCVX)

CUSIP: 92243G108

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 131,352,709
Total 13F shares: 44,022,105
Share change: +1,761,047
Total reported value: $869,193,186
Price per share: $19.75
Number of holders: 73
Value change: +$26,485,491
Number of buys: 46
Number of sells: 31

Quarterly Holders Quick Answers

What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - Vaxcyte, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 92243G108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PCVX - Vaxcyte, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	5.8%	7,642,405	$203,058,000	—	31 Dec 2020	13F
TPG Group Holdings (SBS) Advisors, Inc.	13F	Company	3.8%	4,941,213	$131,288,000	—	31 Dec 2020	13F
Abingworth LLP	13F	Company	3.2%	4,168,718	$110,721,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.2%	4,196,778	$107,538,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	2.8%	3,710,699	$98,593,000	—	31 Dec 2020	13F
FRAZIER MANAGEMENT LLC	13F	Company	1.8%	2,309,554	$61,365,000	—	31 Dec 2020	13F
Pivotal bioVenture Partners Investment Advisor LLC	13F	Company	1.7%	2,222,970	$59,064,000	—	31 Dec 2020	13F
Medicxi Ventures Management (Jersey) Ltd	13F	Company	1.4%	1,887,478	$50,150,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	1.3%	1,693,028	$44,983,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	1.1%	1,449,377	$38,510,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.77%	1,010,850	$26,859,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.7%	921,830	$24,493,000	—	31 Dec 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.65%	850,000	$22,585,000	—	31 Dec 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.48%	630,260	$16,746,000	—	31 Dec 2020	13F
Foresite Capital Management IV, LLC	13F	Company	0.35%	465,821	$12,377,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.32%	425,824	$11,314,000	—	31 Dec 2020	13F
Novo Holdings A/S	13F	Company	0.32%	416,937	$11,078,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.3%	400,076	$10,630,000	—	31 Dec 2020	13F
Opaleye Management Inc.	13F	Company	0.26%	335,200	$8,906,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.23%	300,577	$7,986,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.23%	295,908	$7,863,000	—	31 Dec 2020	13F
Ikarian Capital, LLC	13F	Company	0.21%	276,110	$7,336,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.17%	223,120	$5,929,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.15%	194,811	$5,176,000	—	31 Dec 2020	13F
Logos Global Management LP	13F	Company	0.11%	140,000	$3,720,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	117,593	$3,125,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.06%	72,701	$1,932,000	—	31 Dec 2020	13F
UBS Group AG	13F	Company	0.05%	68,166	$1,811,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.05%	65,940	$1,752,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.05%	64,560	$1,715,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	40,286	$1,070,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.03%	37,491	$996,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	35,721	$949,000	—	31 Dec 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.03%	35,663	$948,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.03%	34,500	$917,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.03%	33,722	$895,000	—	31 Dec 2020	13F
Affinity Asset Advisors, LLC	13F	Company	0.02%	30,000	$797,000	—	31 Dec 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.02%	29,212	$776,000	—	31 Dec 2020	13F
Parkwood LLC	13F	Company	0.02%	28,191	$749,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	27,559	$732,000	—	31 Dec 2020	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.02%	24,782	$718,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	26,400	$701,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	22,397	$595,000	—	31 Dec 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.02%	22,229	$590,000	—	31 Dec 2020	13F
Ensign Peak Advisors, Inc	13F	Company	0.02%	20,873	$555,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.02%	20,000	$531,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	16,500	$438,000	—	31 Dec 2020	13F
Erste Asset Management GmbH	13F	Company	0.01%	14,200	$398,026	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	0.01%	14,426	$383,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	13,782	$366,000	—	31 Dec 2020	13F

Institutional Holders of Vaxcyte, Inc. - Common Stock (PCVX) as of Q1 2021

As of 31 Mar 2021, Vaxcyte, Inc. - Common Stock (PCVX) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,022,105 shares. The largest 10 holders included FMR LLC, TPG Group Holdings (SBS) Advisors, Inc., JANUS HENDERSON GROUP PLC, Abingworth LLP, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, FRAZIER MANAGEMENT LLC, BlackRock Inc., Medicxi Ventures Management (Jersey) Ltd, and STATE STREET CORP. This page lists 73 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

-10

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.